← FDA Drug Approvals (Drugs@FDA)
REPAGLINIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2014-01-22
Drug application
- FDA Application #
ANDA090252- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- REPAGLINIDE
- Generic name
- Repaglinide
- Active ingredients
- REPAGLINIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- QUAGEN
- First approval
- 2014-01-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown